Tools and Resources - COLCRYS® (colchicine, USP) tablets

Home Patients

Download Medication Guide Unapproved Colchicine - Unnecessary risks for patients

Tools and Resources

Patient Assistance Initiatives

We’re here to help. Find out how you may be able to receive COLCRYS at a low out-of-pocket cost.

Helpful Sites

We've included a few sites to help you learn more about gout, its causes, triggers, prevention techniques, and more.

Healthy Body Healthy Minds Video

Video highlights the symptoms of gout, identifies what can cause gout attacks, and explains the importance of early diagnosis and treatment.

Unapproved Drugs Resource Center

The intent of the center is to educate the public on the health risks associated with drugs that have never been approved by the FDA.

FDA Drug Info Rounds

FDA drug Info Rounds.

Additional tools and resources to help you stay up to date on the latest gout-related and COLCRYS information will be available soon.

Check Back Soon

Important Safety Information

COLCRYS^® (colchicine, USP) tablets are used to prevent and treat gout flares.

COLCRYS can cause serious side effects in people with kidney or liver problems who are taking medicines that interfere with COLCRYS. COLCRYS can also cause serious muscle problems. You have a higher chance for muscle problems if you are taking certain other medicines with COLCRYS. Certain medicines when taken with COLCRYS can cause the levels of COLCRYS to be too high in your body. Discuss any health problems you have, as well as medicines you are taking (including non-prescription medications and herbal supplements), with your healthcare provider before starting COLCRYS. The most common side effect in clinical trials for the prevention and treatment of gout was diarrhea.

For more information, refer to the patient Medication Guide in the full Prescribing Information. This information is not intended to replace discussions with a healthcare provider.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

You may also report negative side effects to the manufacturer of COLCRYS by calling 1.888.351.3786.

References: 1. U.S. Food and Drug Administration Web site. Orange Book: Approved Drug Products with Therapentic Equivalence Evaluations. www.accessdata.fda.gov/scripts/cder/ob/docs/tempai.cfm. Accessed September 4,2009. 2. COLCRYS [package insert]. Philadelphia, PA: AR Scientific, Inc. A URL Pharma company; 2009. 3. Data on file, URL Pharma Inc. 4. Merck Manual Professional. Gout: Crystal-Induced Arthritides. http://www.merck.com/mmpe/print/sec04/ch035/ch035b.html. Accessed September 1, 2009. 5. Chen LX, Schumacher HR. Gout: an evidence-based review. J Clin Rheumatol. 2008;14(5 suppl):S55-S62. 6. Merck Manual Home Edition. Gout: Gout and Pseudogout. http://www.merck.com/mmhe/print/sec05/ch070/ch070b.html. Accessed September 1, 2009. 7. Kramer HJ, Choi HK, Atkinson K, Stampfer M, Curhan GC. The association between gout and nephrolithiasis in men: The Health Professionals' Follow-Up Study. Kidney Int. 2003;64(3):1022-1026. 8. Weaver AL. Epidemiology of gout. Cleve Clin J Med. 2008;75(suppl 5:)S9-S12. 9. Wall GC, Cooper SA. Gout and hyperuricemia: new guidelines and treatments. J Pharm Pract. 2009;22:104-115. 10. Gout & Uric Acid Education Society Risk Factors and triggers. http://www.gouteducation.org/gout/factors.aspx. Accessed September 1, 2009.